Alma, a Sisram medical company, introduces PROFHILO® – a landmark new approach in the Indian Anti-ageing treatments market. PROFHILO® is developed by the international pharma company, IBSA.
Alma, one of the top five global leaders of energy-based medical and aesthetics solutions, today announced the launch of renowned European skin-remodeling brand, PROFHILO®, in India, offering a new breakthrough approach in skin anti-ageing. PROFHILO®, developed by the international pharma company, IBSA, created a new concept of ‘Bioremodeling’ in the dermal injectables industry, offering an overarching approach to skin ageing, beyond currently available solutions.
As we age, production of collagen and elastin, the proteins responsible for skin elasticity and firmness, slows down, resulting in skin laxity and sagging skin. PROFHILO® delivers a high concentration of pure Hyaluronic acid to different layers of the skin, promoting the multilevel and dynamic remodeling of extracellular matrix in terms of elasticity and support, while maintaining the viability of fibroblast, keratinocytes, and adipocytes to provide deep hydration and rejuvenation of the skin tissue. With 64 MG of hyaluronic acid per syringe, PROFHILO® delivers the highest concentration of this compound to the skin as compared to other HA-based treatments.
PROFHILO® is administered using a proprietary injection technique, named Bio Aesthetic Points (BAP), which identifies five strategic points to deliver high concentration of pure Hyaluronic acid to different layers of the skin. The BAP technique allows progressive diffusion of the product across widest sections through sub-dermal patterns.
“As a leading global Medical Aesthetics company, we are committed to deliver safe, effective and innovative treatments to our huge customer base across over 90 countries worldwide. This exciting launch of PROFHILO® in India follows its successful launches in Israel and Hong-Kong, and soon in China. Alma, a pioneer in Aesthetics Regenerative Medicine practices, is proud to introduce this new concept of bioremodeling, boosting the production of scaffolding proteins collagen and elastin in the deep layers of skin to address the source of skin laxity and wrinkles.” said Mr. Lior Dayan, Alma’s Chief Executive Officer.
Mr. Lior Dayan further added, “Consumers across the world are seeking anti-ageing solutions that address more than just the outward signs and symptoms of ageing. PROFHILO® is neither a dermal filler nor a skin revitalizer. It is a unique and comprehensive anti-ageing solution that remodels multiple skin layers and achieves lasting results on the skin.”
About PROFHILO® : PROFHILO®’s patented technology blends two different weights of hyaluronic acid (HA) into a single compound. As a result, the hybrid HA cooperative complex are not cross-linked unlike other HA based products in the market. The pure hyaluronic acid compound is also completely biocompatible, implying that it does not cause any harm to the skin.
